With all the time sales representatives spend selling in the field, reading clinical material and arranging or preparing lunches, they rarely have time to sit down and research the personal, financial and other needs of their own lives
With all the time sales representatives spend selling in the field, reading clinical material and arranging or preparing lunches, they rarely have time to sit down and research the personal, financial and other needs of their own lives.
That's one reason why Bristol-Myers Squibb employees appreciate the company's Horizons program.
The program, which was started in 1990 by vice president of training and development Margaret Pyles, is a personal and professional development program that helps reps and other employees in the pharmaceutical group develop their own skills and interests at their own pace. The program consists of two- and three-day seminars, home study courses and educational lunches known as "brown bag seminars."
Currently, more than 4,000 employees participate in the program. In order to qualify for the program, reps have to be a Bristol-Myers Squibb employee for at least six months and a member of the company's pharmaceutical division. In order to attend one of the lengthier seminars, employees must have worked for the company for one year and must have completed at least two home study courses. Sales reps must also demonstrate good sales performance and obtain their manager's approval in order to attend.
To reward completion of a Horizons program seminar or home study course, the company awards points which participants can then "spend" in a Horizons catalog of gifts. Gifts range from cameras and binoculars to stereos and telephones.
To date, the feedback and interest from sales reps and other participating employees has been outstanding.
"It was everything I expected it to be," said Bill Maddox, a central nervous system antibiotics district business manager, from Paducah, KY, who recently attended his first two-day Horizons seminar in Phoenix. "I was very impressed with the way the company was willing to provide this type of personal development. Compared to the other meetings that we go to, which are sales- and marketing-oriented, this was for me and my development."
And investing in employee development, Bristol-Myers Squibb discovered, improves not only its employees' skills, but also their loyalty to the company.
"We looked at field reps who went to Horizons seminars in 1997, and the turnover rate among those people was roughly 0.25%," said Keith. "Everything we do is strictly motivational. It is geared to building loyalty between the company and the Horizons program member."
Sherry Lynn, a neuroscience/anti-infective associate territory business manager from Canyon, TX, deeply appreciated that effort at a Horizons seminar she recently attended.
"One of the things that really moved me was that I really felt Bristol-Myers Squibb had not only an investment in helping me out and helping me be better at my job, but that they also were invested in my having a more profitable life and being a better person," she said. "It was a nice feeling, that a corporation as big as Bristol-Myers Squibb, really cared about me as an individual."
During a time when many sales reps are jumping from one company to another, Bristol-Myers Squibb appears to have found one good way to encourage them to stay. PR
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.